PubMed

Trials that matter: CD4+ T-lymphocyte count-guided interruption of antiretroviral therapy in HIV-infected patients.

Jacobson JM, Turner BJ, Abrutyn E.

Ann Intern Med. 2007 May 1;146(9):682-3. No abstract available. PMID: 17470837 [PubMed - indexed for MEDLINE]Related articlesFree article

Response to "Micronutrient supplementation increases CD4 count in HIV-infected individuals on highly active antiretroviral therapy: a prospective, double-blinded, placebo-controlled trial".

Smith DM.

J Acquir Immune Defic Syndr. 2007 May 1;45(1):128; author reply 128-9; discussion 129. No abstract available. PMID: 17460480 [PubMed - indexed for MEDLINE]Related articles

HIV therapy, guided by CD4 counts.

Laurence J.

AIDS Read. 2006 Apr;16(4):181-2. No abstract available. PMID: 16617927 [PubMed - indexed for MEDLINE]Related articles

Discontinuation of non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy: clinical implications in patients on CD4 T-cell-guided treatment interruption.

Lanzafame M, Lattuada E, Gottardi M, Antolini D, Concia E, Vento S.

AIDS. 2007 Jun 19;21(10):1384-6. No abstract available. PMID: 17545724 [PubMed - indexed for MEDLINE]Related articles

Initial treatment of HIV infection: randomized trials with clinical end points are still needed.

Hughes MD.

J Infect Dis. 2006 Sep 1;194(5):542-4. Epub 2006 Jul 31. No abstract available. PMID: 16897649 [PubMed - indexed for MEDLINE]Related articles

HIV-1 viral rebound dynamics after a single treatment interruption depends on time of initiation of highly active antiretroviral therapy.

Steingrover R, Pogány K, Fernandez Garcia E, Jurriaans S, Brinkman K, Schuitemaker H, Miedema F, Lange JM, Prins JM.

AIDS. 2008 Aug 20;22(13):1583-8.PMID: 18670217 [PubMed - indexed for MEDLINE]Related articles

Initial strategy for antiretroviral-naive patients.

Abgrall S.

Lancet. 2006 Dec 16;368(9553):2107-9. No abstract available. PMID: 17174691 [PubMed - indexed for MEDLINE]Related articles

Interleukin-2--where are we going?

Conrad A.

J Assoc Nurses AIDS Care. 2003 Nov-Dec;14(6):83-8. Review.PMID: 14682072 [PubMed - indexed for MEDLINE]Related articles

Risk of discontinuation of nevirapine due to toxicities in antiretroviral-naive and -experienced HIV-infected patients with high and low CD4+ T-cell counts.

Mocroft A, Staszewski S, Weber R, Gatell J, Rockstroh J, Gasiorowski J, Panos G, Monforte A, Rakhmanova A, Phillips AN, Lundgren JD; EuroSIDA study group.

Antivir Ther. 2007;12(3):325-33. Erratum in: Antivir Ther. 2007;12(4):577. PMID: 17591022 [PubMed - indexed for MEDLINE]Related articles

Lipid and apoprotein profile in HIV-1-infected patients after CD4-guided treatment interruption.

Seoane E, Resino S, Micheloud D, Moreno A, de Quiros JC, Lorente R, Rubio R, Gonzalez J, Pulido F, Arribas JR, Moreno S, Muñoz-Fernández M.

J Acquir Immune Defic Syndr. 2008 Aug 1;48(4):455-9.PMID: 18614926 [PubMed - indexed for MEDLINE]Related articles

Immunological predictors of CD4+ T cell decline in antiretroviral treatment interruptions.

Seoane E, Resino S, Moreno S, de Quiros JC, Moreno A, Rubio R, Gonzalez-García J, Arribas JR, Pulido F, Muñoz-Fernández MA.

BMC Infect Dis. 2008 Feb 26;8:20.PMID: 18302775 [PubMed - indexed for MEDLINE]Related articlesFree article

[Preventing development of resistance. High potency first-line regimen permit new therapy planning]

[No authors listed]

MMW Fortschr Med. 2002 Aug 22;144(33-34):50-1. German. No abstract available. PMID: 12380144 [PubMed - indexed for MEDLINE]Related articles

[CD4+ guided interruption HAART in HIV patients]

Antolini D, Lanzafame M, Lattuada E, Vento S, Concia E.

Recenti Prog Med. 2007 Oct;98(10):501-5. Italian. PMID: 17970175 [PubMed - indexed for MEDLINE]Related articles

Chronic HIV infection.

Jacobs B, Aboulafia DM.

Ann Intern Med. 2003 Mar 4;138(5):437-8. No abstract available. PMID: 12614105 [PubMed - indexed for MEDLINE]Related articlesFree article

The risk of treatment versus the risk of HIV replication.

Deeks SG.

Lancet. 2006 Jun 17;367(9527):1955-6. No abstract available. PMID: 16782465 [PubMed - indexed for MEDLINE]Related articles

Costing implications of recent treatment interruption studies.

Gill MJ, Krentz HB.

AIDS. 2006 Nov 14;20(17):2239-40. No abstract available. PMID: 17086069 [PubMed - indexed for MEDLINE]Related articles

Total lymphocyte count as a surrogate marker for CD4+ t cell count in initiating antiretroviral therapy at Kenyatta National Hospital, Nairobi.

Gitura B, Joshi MD, Lule GN, Anzala O.

East Afr Med J. 2007 Oct;84(10):466-72.PMID: 18232267 [PubMed - indexed for MEDLINE]Related articles

Microbial translocation is associated with sustained failure in CD4+ T-cell reconstitution in HIV-infected patients on long-term highly active antiretroviral therapy.

Marchetti G, Bellistrì GM, Borghi E, Tincati C, Ferramosca S, La Francesca M, Morace G, Gori A, Monforte AD.

AIDS. 2008 Oct 1;22(15):2035-8.PMID: 18784466 [PubMed - indexed for MEDLINE]Related articles

Recent research in HIV infection: Part I.

Boyle BA.

AIDS Read. 2002 Nov;12(11):477-8, 483-5. Review. No abstract available. PMID: 12494908 [PubMed - indexed for MEDLINE]Related articles

Trends in opportunistic infections in the pre- and post-highly active antiretroviral therapy eras among HIV-infected children in the Perinatal AIDS Collaborative Transmission Study, 1986-2004.

Nesheim SR, Kapogiannis BG, Soe MM, Sullivan KM, Abrams E, Farley J, Palumbo P, Koenig LJ, Bulterys M.

Pediatrics. 2007 Jul;120(1):100-9.PMID: 17606567 [PubMed - indexed for MEDLINE]Related articlesFree article